CORRECTED: Packard and Microarrays | GenomeWeb

NEW YORK, Jan 17 – A January 8 story about Packard BioScience has been clarified to reflect the company’s decision not to commercialize DNA chips, not microarrays, as previously stated. While the company has decided not to market DNA chips, Packard BioScience still intends to sell its microarray technology and to manufacture and sell protein chips.

The archived version of the story has been altered to more clearly reflect the company’s plans.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.